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ABSTRACT
Objective: Mitochondrial disorders linked to thymidine kinase 2 (TK2) deficiency are associated with long-term treatment with antiviral nucleoside 
analogs such as azidothymidine (AZT). The accumulation of AZT-triphosphate affects deoxyribonucleic acid (DNA) polymerase, resulting in 
mitochondrial DNA depletion. Thus, a potent and selective inhibitor for TK2 is essential to be predicted.
Methods: The human mitochondrial TK2 was modeled using a modeler, and the structure was evaluated using Ramachandran Plot. The ligand 
molecule of both the derivatives of deoxythymidine (dThd) and thiourea was optimized using ChemSketch and was further docked using grid-based 
ligand docking with energetics Schrödinger package 2009.
Results: The human mitochondrial TK2 was modeled and the structure was validated using Procheck which had 90.1% of residues in the most 
favorable regions and 8.8% of residues in the allowed regions with 8 glycine residues and 10 proline residues. Docking analysis was carried out 
against the ligands selected from the dThd and thiourea derivatives, out of which 6, 8F, 8G, 8H, and 14B ligands had significant interacting poses 
with target protein TK2. In Ligand 6, the best interaction is found to be at 163 Glu molecule with a distance of 2.8Å; in Ligand 8F, 172 Tyr, 63 Tyr, and 
164 Glu with a distance of 2.8 Å; in Ligand 8G, 74 Gln with a distance of 2.7 Å, and in Ligand 14B, 107 Phe with a distance of 2.9 Å. From this, the dThd 
analog (Ligand 14B) could be a potent and selective inhibitor of TK2.
Conclusion: The present study indicated that dThd derivatives interacted significantly and hence serve as selective inhibitors against human 
mitochondrial TK2.
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INTRODUCTION
In mammalian cells, there are two deoxyribonucleoside kinases that 
can phosphorylate thymidine, namely cytosolic thymidine kinase (TK1) 
and mitochondrial TK2 [1]. TK2, encoded on chromosome 16q22 of 
the human genome, was a deoxynucleoside kinase that catalyzes the 
phosphorylation of the pyrimidine deoxynucleosides 2’-deoxythymidine 
(dThd), 2’-deoxyuridine (dUrd), and 2’- deoxycytidine (dCyd) to the 
corresponding deoxynucleoside 5’-monophosphate derivatives [2]. 
Deficiency in TK2 activity due to genetic alterations causes devastating 
mitochondrial diseases, which were characterized by mitochondrial 
deoxyribonucleic acid (mtDNA) depletion or multiple deletions in 
the affected tissues [3]. Deoxyribonucleoside kinases phosphorylate 
deoxyribonucleosides, a crucial reaction in biosynthesis of DNA 
precursors through the salvage pathway. Both TKs show important 
differences in their primary amino acid sequences, substrate 
specificities, and levels of expression in the different phases of the cell 
cycle [4]. The amino acid sequence of the TK1 enzymes was unique in its 
group whereas TK2 belongs to a larger group of nucleosides. AZT was 
an excellent substrate for TK1 and it was a poor substrate for TK2 [5]. 
Two of the four human deoxyribonucleoside kinases, deoxyguanosine 
kinase and TK2, were expressed in mitochondria. Human diacylglycerol 
kinases efficiently phosphorylate deoxyguanosine and deoxyadenosine, 
whereas TK2 phosphorylates dThd, dCyd, and dUrd. Mutations in TK2 
represent a new etiology for mitochondrial DNA depletion, underscoring 
the importance of the mitochondrial deoxyribonucleotide (dNTP) pool 
in the pathogenesis of mitochondrial depletion [6]. The accumulation 
of AZT-TP was suggested to affect DNA polymerase resulting in mtDNA 
depletion [7,8]. DNA polymerase-γ (pol-γ) was part of an assembly of 
proteins and enzymes responsible for the replication of mtDNA. AZT-TP 
is one of the analogs least likely to be incorporated into DNA by DNA 
pol-γ, but once AZT-MP is incorporated, it is not efficiently removed 
from DNA by the DNA pol-γ exonuclease function [4,9].
METHODS
Homology modeling
The protein sequence of human mitochondrial TK2 was obtained from 
the NCBI (http://www.ncbi.nlm.nih.gov/). BLASTP was used to identify 
the most suitable template based on sequence identity and score 
for homology modeling of human mitochondrial TK2. The available 
structure was Drosophila melanogaster nucleoside (PDB ID: 1OT3) and 
was used as template. The homology modeling was carried out using 
Modeller 9V7 (Fig. 1). Modeller is a computer program that models 
three-dimensional (3D) structure of proteins and their assemblies 
by satisfaction of spatial restraints. The core modeling procedure 
begins with an alignment of the sequence to be modeled (target) with 
related known 3D structure (template). Then, the spatial features, such 
as Cα-Cα distance, hydrogen bonds, and main chain and side chain 
dihedral angles, are transferred from the templates to the target [10].
Structure validation
The structure verification program PROCHECK was used to evaluate 
the quality of the modeled 3D structure of mitochondrial TK2. The 
above-mentioned validation program validates the predicted structure 
by checking various parameters. PROCHECK, a structure verification 
program relies on Ramachandran plot (Fig. 2), determines the quality 
of the predicted structure by assessing various parameters such as 
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lengths, angles, and planarity of the peptide bonds, geometry of the 
hydrogen bonds, and side chain conformations of protein structures as 
a function of atomic resolution [10,11].
Protein preparation
The protein preparation consists of two components, preparation 
and refinement. After ensuring chemical correctness, the preparation 
component adds hydrogen and neutralizes side chains that were not 
close to the binding cavity and did not participate in salt bridges. The 
refinement component performs a restrained impact minimization of 
the co-crystallized complex, which reorients side chain hydroxyl groups 
and alleviates potential steric clashes.
Ligand preparation
All the ligand structures (dThd/thiourea analogs) were taken from 
literature (Table 1). Ligand structures were drawn using ChemSketch. 
ACD/ChemSketch is the powerful chemical drawing and graphics package 
from ACD/labs software, which will draw molecular structures, reactions, 
and calculate chemical properties very quickly and easily [12]. The crystal 
structure was then refined, and the geometries were optimized with the 
OPLS-2005 force field using standard protocol and parameters [13].
Fig. 1: Modeled structure of human mitochondrial thymidine 
kinase 2 using Drosophila melanogaster nucleoside as template 
(PDB ID: 1OT3)
Fig. 2: Ramachandran plot for the modeled protein structure
Molecular docking
Molecular docking is the formation of non-covalent 
protein-ligand complexes in drug design. In the specified structure 
of a protein and a ligand, the task is predicting the structure of 
the binder complex. A docking technique evaluates the forces 
involved in the protein- ligand recognition such as Van der Waals 
bonding through hydrogen, electrostatic and place of the 
ligand appropriately in the active site [14]. These studies were 
done using grid-based ligand docking with energetics (GLIDE), and the 
crystal structure was cleaned by deleting the ligand and the 
cofactors. This was followed by adding hydrogen atoms in their 
standard geometry, adjusting the bond orders and formal charges. The 
crystal structure was then refined, and the geometries were 
optimized [13].
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Docking analysis using Maestro
Maestro is a graphical user interface for all Schrödinger’s products. 
It contains tools for building, displaying, and manipulating chemical 
structures; for organizing, loading, and storing these structures and 
associated data; and also setting up, monitoring, and visualizing the 
results of calculations on these structures [15].
Grid generation
Choose receptor grid generation from the glide submenu of the 
applications menu. The receptor grid generation panel has three tabbed 




Specifying the receptor grid
To specify the receptor grid for the docking job, click browse in the 
receptor grid section of the settings folder to open a file selector and 
choose a grid file (grd). The file name, without the grd extension, is 
displayed in the Receptor grid base name text box. We can also enter 
the base name directly into the text box [16].
Induced fit docking
Glide docking uses the assumption of a rigid receptor although scaling 
of Van der Waals radii of non-polar atoms decreases penalties for 
close contacts. The induced fit docking allows the receptor to alter its 
binding sites so that it more closely conforms to the shape and binding 
mode of the ligand. Docking of both dThd and thiourea derivatives 
is done against the target TK2. The best glide energy and dock score 
were seen for the ligands. The best ligands were chosen for induced 
fit docking. Schrödinger has developed a Python script that automates 
the induced fit docking process. This Python script has an interface in 
Maestro, in which one can specify the structures and enter settings for 
various options, and then run the job. The structures used for induced 
fit docking must be prepared in the same manner as for GLIDE [17,18].
RESULTS AND DISCUSSION
The human mitochondrial TK2 protein was modeled and the structure 
was validated using PROCHECK.
The percentage of residues for the modeled protein that were present 
in the most favorable regions of Ramachandran plot is 90.1%, whereas 
in allowed regions (a, b, l, p), it corresponds to give 8.8%. The number 
of glycine and proline residues was 8 and 10, respectively.
The ligands of both dThd and thiourea derivatives were drawn in 
ChemSketch and were docked against the target protein using GLIDE. 
The results were shown in Table 2.
From the results obtained, upon induced fit docking of the selected 
ligands, only 6, 8F, 8G, 8H, and 14B had significant interacting poses 
with the target protein TK2. Among the several poses generated, only 
the pose of the first and best showing docking score/glide energy was 
represented in the present study (Table 3).
The ligands interacted with the modeled human mitochondrial TK2 
protein by forming hydrogen bonds.
The hydrogen bond interaction between the ligand and the protein 
occurs through the following residues:
The Ligand 6 (thiourea derivative) had a dock score of −9.10 with a glide 
energy of −59.11 Kcal/mol and interacted with 51 Arg with a distance 
of 3.0 Å, 163 Glu with a distance of 2.8 Å, 165 Glu with a distance of 3.5 
Å, 160 Arg with a distance of 3.1 Å, 165 Glu with a distance of 3.3 Å, 164 
Glu with a distance of 3.2 Å, and 63 Tyr with a distance of 3.1 Å.
The Ligand 8F (dThd analogs) had a dock score of −8.29 with a glide 
energy of −59.49 Kcal/mol and interacted with 172 Tyr with a distance 
of 2.8 Å, 63 Tyr with a distance of 2.8 Å, and 164 Glu with a distance of 
2.8 Å.
The Ligand 8G (dThd analogs) had a dock score of −9.59 with a glide 
energy of −56.51 Kcal/mol and interacted with 172 Tyr with a distance 
of 2.9 Å, 74 Gln with a distance of 2.7 Å, and 98 Arg with a distance of 
3.2 Å.
The Ligand 8H (dThd analogs) had a dock score of −9.78 with a glide 
energy of −57.06 Kcal/mol and interacted with 24 Ala with a distance 
of 3.3 Å, 27 Lys with a distance of 3.1 Å, 27 Lys with a distance of 3.1 Å, 
98 Arg with a distance of 3.2 Å, and 74 Gln with a distance of 3.1 Å.
The Ligand 14B (bromovinyl derivative) had a dock score of −8.44 
with a glide energy of −66.68 Kcal/mol and interacted with 45 Glu with 
a distance of 3.3 Å, 107 Phe with a distance of 2.9 Å, 172 Tyr with a 
distance of 2.8 Å, 63 Tyr with a distance of 3.2 Å, and 63 Tyr with a 
distance of 3.1 Å.
Mitochondrial DNA replication occurs throughout the whole cell cycle. 
This means that dNTPs are constantly required for mtDNA synthesis. 
If efficient targeting of TK2 inhibitors to the mitochondria becomes an 
achievable goal, it will become easier to investigate the role of TK2 in 
mitochondrial toxicity of antiviral and anticancer compounds, as well 
as other important issues such as mitochondrial homeostasis and 
integrity, the dynamics of mitochondrial dNTP pools, mitochondrial 
DNA repair, the possible existence of a substrate cycle between TK2 
and mitochondrial nucleotidase(s), and the communication between 
mitochondria and the cytosol/nucleus [19]. In this study, dThd analogs 
and thiourea derivatives have been analyzed and Ligand 14B has been 
emerged as a selective inhibitor which could help in further analysis in 
reducing mtDNA depletion syndrome.
CONCLUSION
The accumulation of AZT-TP was suggested to affect DNA polymerase 
resulting in mtDNA depletion syndrome. AZT-TP was formed as a result 
of phosphorylation of AZT by TK2. Hence, by inhibiting the action of 
TK2, phosphorylation of AZT could be controlled which automatically 
reduces the chances of mtDNA depletion syndrome. The earlier 
identified inhibitors of TK2 were of thiourea derivatives. By replacing 
the thiourea linker of an earlier identified TK2 inhibitor Ligand 6 by a 1, 
4-substituted triazole ring (dThd analogs), a new generation of potent 
Table 2: Docking results of both dThd and thiourea derivatives 






8F −8.28 −50.19 74 Gln N-H…O 2.8
74 GlnN-H…O 3.3
8H −7.38 −45.94 74 Gln N-H…O 3.2
45 Glu N-H…O 3.0
8H −6.86 −44.27 45 Glu N-H…O 3.0
74 Gln N-H…O 3.2
8G −6.70 −46.16 No interaction
6 −6.59 −49.46 45 Glu N-H…O 2.9
24 Ala N-H…O 3.2
14A −6.58 −45.72 65 Glu O-H…O 2.7
14B −5.97 −49.05 51 Arg N-H…O 2.8
65 Glu O-H…O 2.7
8D −5.61 −29.52 No interaction
8I −5.37 −19.87 24 Ala N-H…O 3.1
8J −5.20 −37.68 No interaction
8A −5.05 −26.82 98 Arg N-H…O 2.6
51 Arg N-H…O 3.1
8E −4.93 −36.03 51 Arg N-H…O 3.1
8C −4.60 −28.85 51 Arg N-H…O 3.3
8B −4.51 −31.25 51 Arg N-H…O 3.0
TK2: Thymidine kinase 2, dThd: Deoxythymidine
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TK2 inhibitors was generated. Docking results showed that dThd analogs 
have good energy and comparable score as of Ligand 6. Ligand 14B has 
a best docking score (−9.05) and glide energy (−66.81) compared to 
the existing inhibitors of Ligand 6 which has score (−9.10) and energy 
(−59.11). Hydrogen bonding of Ligand 14B was also similar to that of 
thiourea derivative (Ligand 6). Hence, dThd analogs (Ligand 14B) have 
been emerged as potent and selective inhibitors of TK2.
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